07:19 AM EDT, 10/18/2024 (MT Newswires) -- CVS Health ( CVS ) said Friday it has named its Executive Vice 20and CVS Caremark President, David Joyner as President and Chief Executive Officer, starting Oct. 17.

Joyner was also appointed to the company's Board of Directors. Joyner is succeeding Karen Lynch, who has decided to step down "in agreement" with the company's board, CVS Health ( CVS ) said.

In addition, CVS Health ( CVS ) said the current Chairman of the board Roger Farah was named Executive Chairman.

The company also said it expects Q3 adjusted EPS of $1.05 to $1.10. CVS Health ( CVS ) said its Q3 results include charges to record premium deficiency reserves of around $1.1 billion that lowered its Q3 adjusted EPS by $0.63. Analysts surveyed by Capital IQ expect $1.70.

Price: 56.30, Change: -7.37, Percent Change: -11.58